Healthcare investors think OpenAI could build a personal health assistant complete with medical records, a project that's ...

OpenAI is testing the waters of the $5 trillion healthcare industry. Sources close to the company say the AI powerhouse is ...

Wondering if Doximity is a hidden gem or priced to perfection? You are not alone. There is a lot to unpack for curious investors diving into the stock's current value. Recent headlines might have ...

What Happened? A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, ...

Revenue: $169 million for Q2 fiscal 2026, 23% year-on-year growth. Adjusted EBITDA Margin: 68% or $101 million, 15% above guidance. Free Cash Flow: Up 37% year-on-year. Net Revenue Retention Rate: 118 ...

Doximity saw 14 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Doximity’s stock price’s past reactions to earnings here. According to InvestingPro, Doximity’s Financial ...

On November 3, 2025, Morgan Stanley maintained its Equal-Weight rating on Doximity and held its price target steady at $62.

Doximity, Inc. (NYSE: DOCS) is one of the stocks Jim Cramer mentioned in his latest comments. During the lightning round, a caller mentioned that they were not sure if they should sell their position ...

Shares of Doximity (DOCS) traded ~14% lower on Friday despite reporting better-than-expected Q2 FY26 financials after the digital medical platform flagged concerns over healthcare-policy-related ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Doximity (DOCS), which belongs to the Zacks ...